---

title: BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
url: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&f=G&l=50&d=PALL&S1=08586754&OS=08586754&RS=08586754
owner: AbbVie Inc.
number: 08586754
owner_city: North Chicago
owner_country: US
publication_date: 20100603
---
